These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 349422)

  • 1. [A double-blind clinical study of the effect of a new molecule (+)-cyanidanol-3 on the course of the clinical symptoms and biological parameters of viral hepatitis].
    Cachin M; Dupuy R; Boutelier D; Levy C
    Minerva Dietol Gastroenterol; 1977; 23(4):307-12. PubMed ID: 349422
    [No Abstract]   [Full Text] [Related]  

  • 2. [The treatment of acute viral hepatitis with (+)-cyanidanol-3].
    Pelloni S; Berthet P; Blum AL; Doelle W; Goebell H; Kortüm K; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Schweiz Med Wochenschr; 1977 Dec; 107(49):1859-61. PubMed ID: 337476
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influence of (+)-cyanidanol-3 on the course of acute viral hepatitis (author's transl)].
    Vido I; Schmidt FW; Müller R; Ranft U; Wildhirt E; Holzer E; Wallnöfer H; Korb G
    Dtsch Med Wochenschr; 1980 Mar; 105(10):330-2. PubMed ID: 6153953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute viral hepatitis with (+)-cyanidanol-3.
    Blum AL; Berthet P; Doelle W; Goebell H; Kortüm K; Pelloni S; Peter P; Poulsen H; Strohmeyer G; Tygstrup N
    Lancet; 1977 Dec; 2(8049):1153-5. PubMed ID: 73062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preliminary evaluation of catergen (Zyma) in the treatment of acute viral hepatitis (author's transl)].
    Sowa J; Odrobina S; Mossor-Ostrowska J
    Przegl Lek; 1980; 37(7):573-7. PubMed ID: 6997933
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of therapeutic effect of catergen in viral hepatitis].
    Boroń P; Boroń-Kaczmarska A; Sokolewicz-Bobrowska E; Szpakowicz T; Nadowska K
    Pol Tyg Lek; 1979 Aug; 34(33):1315-7. PubMed ID: 117435
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of (+)-cyanidanol-3- on acute viral hepatitis. Preliminary results].
    Guadagnino V; De Mercato R; Piazza M
    Clin Ter; 1977 Dec; 83(5):463-8. PubMed ID: 608309
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is (+)-Cyanidole-3 an effective therapeutic agent in liver diseases?].
    Blum AL
    Dtsch Med Wochenschr; 1978 May; 103(21):877. PubMed ID: 648373
    [No Abstract]   [Full Text] [Related]  

  • 9. [A new therapy of hepatic insufficiency. Experiments with (+)-3--cyanidanol. Its importance in the treatment of alcoholic hepatitis].
    Traissac FJ; Borg R
    Minerva Dietol Gastroenterol; 1977; 23(3):237-42. PubMed ID: 372845
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L; Poznańska H; Rychalska B
    Przegl Epidemiol; 1981; 35(4):471-7. PubMed ID: 6803308
    [No Abstract]   [Full Text] [Related]  

  • 11. [Usefulness of Catergen (ZYMA) in the treatment of viral hepatitis].
    Rzeszowska G; Patorska-Mach E; Mierzejewska I; Radomińska I; Modrzewska R; Pomorska M
    Pol Tyg Lek; 1981 Mar; 36(9):327-9. PubMed ID: 7022412
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of (+)-cyanidanol-3 in the treatment of chronic active hepatitis (author's transl)].
    Demeulenaere F; Desmet VJ; Dupont E; Fiasse R; Gisselbrecht H; Heully F; Jeanpierre R; Lecomte J; Lennes G; Macinot C; Migeotte P; Pirotte J; Rauber G; Ruyters L; Van Cauwenberge H
    Gastroenterol Clin Biol; 1981 Mar; 5(3):314-23. PubMed ID: 7014344
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of therapy in chronic liver diseases. Double-blind study with cianidanol].
    Machalke K; Müller B
    Fortschr Med; 1982 Apr; 100(14):665-7. PubMed ID: 6123478
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of (+)-cyanidanol-3 in acute HAV, HBV, and non-A, non-B viral hepatitis.
    Piazza M; Guadagnino V; Picciotto L; De Mercato R; Chirianni A; Orlando R; Golden G
    Hepatology; 1983; 3(1):45-9. PubMed ID: 6401668
    [No Abstract]   [Full Text] [Related]  

  • 15. [(+)-Cyanidanol-3 in the treatment of acute viral hepatitis in childhood].
    Musso A; Vietti Ramus M; Sacchetti C; Giacchino M; Vaccino P
    Minerva Pediatr; 1980 May; 32(10):711-24. PubMed ID: 7453677
    [No Abstract]   [Full Text] [Related]  

  • 16. (+)-Cyanidanol-3 in the treatment of acute viral hepatitis: a randomized controlled trial.
    Schomerus H; Wiedmann KH; Dölle W; Peerenboom H; Strohmeyer G; Balzer K; Goebell H; Dürr HK; Bode C; Blum AL
    Hepatology; 1984; 4(2):331-5. PubMed ID: 6368355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [What is certain in the therapy of hepatocellular diseases with cyanidanol?].
    Schomerus H
    Internist (Berl); 1983 Dec; 24(12):684-9. PubMed ID: 6363332
    [No Abstract]   [Full Text] [Related]  

  • 18. (+)-cyanidanol-3 in acute viral hepatitis.
    Blum AL
    Lancet; 1978 Mar; 1(8062):501-2. PubMed ID: 76044
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
    Bar-Meir S; Halpern Z; Gutman M; Shpirer Z; Baratz M; Bass D
    Gut; 1985 Sep; 26(9):975-9. PubMed ID: 3896964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The development of cianidanol and 3-palmitoyl-(+)-catechin as drugs for the treatment of liver diseases.
    Perrissoud D
    Prog Clin Biol Res; 1986; 213():559-69. PubMed ID: 3520595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.